Characterization of a bacteriophage lysin (Ply700) from Streptococcus uberis

Veterinary Microbiology

Volumn 130, Issue 1-2, 2008, Pages 107-117

  Celia, Laura K ^a   Nelson, Daniel ^b   Kerr, David E ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Antibacterial; Antibiotic; Mastitis

Indexed keywords

BACTERIAL PROTEIN; GREEN FLUORESCENT PROTEIN; MITOMYCIN C; PROTEIN LYSIN;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ESCHERICHIA COLI; NONHUMAN; PLATE COUNT; PROPHAGE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS UBERIS;

CLONING, MOLECULAR; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; PROPHAGES; STREPTOCOCCUS; STREPTOCOCCUS PHAGES; VIRAL PROTEINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS UBERIS;

EID: 46549084493     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2007.12.004     Document Type: Article

References (23)

1. Bramley A.J., and Foster R. Effects of lysostaphin on Staphylococcus aureus infections of the mouse mammary gland. Res. Vet. Sci. 49 (1990) 120-121
2. Cheng Q., and Fischetti V.A. Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci. Appl. Microbiol. Biotechnol. 74 (2007) 1284-1291
3. Cheng Q., Nelson D., Zhu S., and Fischetti V.A. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob. Agents Chemother. 49 (2005) 111-117
4. Chockalingam A., McKinney C.E., Rinaldi M., Zarlenga D.S., and Bannerman D.D. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis. Vet. Microbiol. 125 (2007) 80-90
5. Donovan D.M., Dong S., Garrett W., Rousseau G.M., Moineau S., and Pritchard D.G. Peptidoglycan hydrolase fusions maintain their parental specificities. Appl. Environ. Microbiol. 72 (2006) 2988-2996
6. Donovan D.M., Foster-Frey J., Dong S., Rousseau G.M., Moineau S., and Pritchard D.G. The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain. Appl. Environ. Microbiol. 72 (2006) 5108-5112
7. Guzman L.M., Belin D., Carson M.J., and Beckwith J. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177 (1995) 4121-4130
8. Hassan A.A., Khan I.U., Abdulmawjood A., and Lammler C. Evaluation of PCR methods for rapid identification and differentiation of Streptococcus uberis and Streptococcus parauberis. J. Clin. Microbiol. 39 (2001) 1618-1621
9. Hill A.W., and Brady C.A. A note on the isolation and propagation of lytic phages from Streptococcus uberis and their potential for strain typing. J. Appl. Bacteriol. 67 (1989) 425-431
10. Kerr D.E., Plaut K., Bramley A.J., Williamson C.M., Lax A.J., Moore K., Wells K.D., and Wall R.J. Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice. Nat. Biotechnol. 19 (2001) 66-70
11. Loeffler J.M., Djurkovic S., and Fischetti V.A. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect. Immun. 71 (2003) 6199-6204
12. Loeffler J.M., Nelson D., and Fischetti V.A. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294 (2001) 2170-2172
13. Loessner M.J., Kramer K., Ebel F., and Scherer S. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol. Microbiol. 44 (2002) 335-349
14. Marchler-Bauer A., Anderson J.B., Derbyshire M.K., DeWeese-Scott C., Gonzales N.R., Gwadz M., Hao L., He S., Hurwitz D.I., Jackson J.D., Ke Z., Krylov D., Lanczycki C.J., Liebert C.A., Liu C., Lu F., Lu S., Marchler G.H., Mullokandov M., Song J.S., Thanki N., Yamashita R.A., Yin J.J., Zhang D., and Bryant S.H. CDD: a conserved domain database for interactive domain family analysis. Nucleic Acids Res. 35 (2007) D237-D240
15. Nelson D., Loomis L., and Fischetti V.A. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 4107-4112
16. Neville M.C. Calcium secretion into milk. J. Mammary Gland Biol. Neoplasia 10 (2005) 119-128
17. Oldham E.R., and Daley M.J. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic. J. Dairy Sci. 74 (1991) 4175-4182
18. Pritchard D.G., Dong S., Baker J.R., and Engler J.A. The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology 150 (2004) 2079-2087
19. Schuch R., Nelson D., and Fischetti V.A. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418 (2002) 884-889
20. Sheehan M.M., Garcia J.L., Lopez R., and Garcia P. The lytic enzyme of the pneumococcal phage Dp-1: a chimeric lysin of intergeneric origin. Mol. Microbiol. 25 (1997) 717-725
21. Smith D.L., Harris A.D., Johnson J.A., Silbergeld E.K., and Morris Jr. J.G. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6434-6439
22. Sordillo L.M., and Streicher K.L. Mammary gland immunity and mastitis susceptibility. J. Mammary Gland Biol. Neoplasia 7 (2002) 135-146
23. Wall R.J., Powell A.M., Paape M.J., Kerr D.E., Bannerman D.D., Pursel V.G., Wells K.D., Talbot N., and Hawk H.W. Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat. Biotechnol. 23 (2005) 445-451